BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1061 related articles for article (PubMed ID: 20888706)

  • 1. Intensity-modulated radiotherapy for locally advanced non-small-cell lung cancer: a dose-escalation planning study.
    Lievens Y; Nulens A; Gaber MA; Defraene G; De Wever W; Stroobants S; Van den Heuvel F;
    Int J Radiat Oncol Biol Phys; 2011 May; 80(1):306-13. PubMed ID: 20888706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: a comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation.
    Grills IS; Yan D; Martinez AA; Vicini FA; Wong JW; Kestin LL
    Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):875-90. PubMed ID: 14529795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IMRT and 3D conformal radiotherapy with or without elective nodal irradiation in locally advanced NSCLC: A direct comparison of PET-based treatment planning.
    Fleckenstein J; Kremp K; Kremp S; Palm J; RĂ¼be C
    Strahlenther Onkol; 2016 Feb; 192(2):75-82. PubMed ID: 26438071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose heterogeneity in the target volume and intensity-modulated radiotherapy to escalate the dose in the treatment of non-small-cell lung cancer.
    Schwarz M; Alber M; Lebesque JV; Mijnheer BJ; Damen EM
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):561-70. PubMed ID: 15890601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of heart and coronary artery doses associated with intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for distal esophageal cancer.
    Kole TP; Aghayere O; Kwah J; Yorke ED; Goodman KA
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1580-6. PubMed ID: 22284687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Volumetric modulation arc radiotherapy with flattening filter-free beams compared with static gantry IMRT and 3D conformal radiotherapy for advanced esophageal cancer: a feasibility study.
    Nicolini G; Ghosh-Laskar S; Shrivastava SK; Banerjee S; Chaudhary S; Agarwal JP; Munshi A; Clivio A; Fogliata A; Mancosu P; Vanetti E; Cozzi L
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):553-60. PubMed ID: 22386376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Toxicity Between Intensity-Modulated Radiotherapy and 3-Dimensional Conformal Radiotherapy for Locally Advanced Non-small-cell Lung Cancer.
    Ling DC; Hess CB; Chen AM; Daly ME
    Clin Lung Cancer; 2016 Jan; 17(1):18-23. PubMed ID: 26303127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non-small-cell lung cancer.
    Liu HH; Wang X; Dong L; Wu Q; Liao Z; Stevens CW; Guerrero TM; Komaki R; Cox JD; Mohan R
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1268-79. PubMed ID: 15001272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non-small-cell lung cancer.
    Chang JY; Zhang X; Wang X; Kang Y; Riley B; Bilton S; Mohan R; Komaki R; Cox JD
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1087-96. PubMed ID: 16682145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer.
    Murshed H; Liu HH; Liao Z; Barker JL; Wang X; Tucker SL; Chandra A; Guerrero T; Stevens C; Chang JY; Jeter M; Cox JD; Komaki R; Mohan R
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1258-67. PubMed ID: 15001271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of anisotropic aperture based intensity modulated radiotherapy with 3D-conformal radiotherapy for the treatment of large lung tumors.
    Simeonova A; Abo-Madyan Y; El-Haddad M; Welzel G; Polednik M; Boggula R; Wenz F; Lohr F
    Radiother Oncol; 2012 Feb; 102(2):268-73. PubMed ID: 22100654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of active breathing control-moderate deep inspiration breath-hold in definitive non-small cell lung cancer radiotherapy.
    Sager O; Beyzadeoglu M; Dincoglan F; Oysul K; Kahya YE; Gamsiz H; Uysal B; Demiral S; Dirican B; Surenkok S
    Neoplasma; 2012; 59(3):333-40. PubMed ID: 22296503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensity-modulated proton therapy reduces the dose to normal tissue compared with intensity-modulated radiation therapy or passive scattering proton therapy and enables individualized radical radiotherapy for extensive stage IIIB non-small-cell lung cancer: a virtual clinical study.
    Zhang X; Li Y; Pan X; Xiaoqiang L; Mohan R; Komaki R; Cox JD; Chang JY
    Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):357-66. PubMed ID: 19660879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraindividual comparison of conventional three-dimensional radiotherapy and intensity modulated radiotherapy in the therapy of locally advanced non-small cell lung cancer a planning study.
    Marnitz S; Stuschke M; Bohsung J; Moys A; Reng I; Wurm R; Budach V
    Strahlenther Onkol; 2002 Nov; 178(11):651-8. PubMed ID: 12426677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment planning comparison between conformal radiotherapy and helical tomotherapy in the case of locally advanced-stage NSCLC.
    Cattaneo GM; Dell'oca I; Broggi S; Fiorino C; Perna L; Pasetti M; Sangalli G; di Muzio N; Fazio F; Calandrino R
    Radiother Oncol; 2008 Sep; 88(3):310-8. PubMed ID: 18692266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A potential to reduce pulmonary toxicity: the use of perfusion SPECT with IMRT for functional lung avoidance in radiotherapy of non-small cell lung cancer.
    Lavrenkov K; Christian JA; Partridge M; Niotsikou E; Cook G; Parker M; Bedford JL; Brada M
    Radiother Oncol; 2007 May; 83(2):156-62. PubMed ID: 17493699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased therapeutic ratio by 18FDG-PET CT planning in patients with clinical CT stage N2-N3M0 non-small-cell lung cancer: a modeling study.
    van Der Wel A; Nijsten S; Hochstenbag M; Lamers R; Boersma L; Wanders R; Lutgens L; Zimny M; Bentzen SM; Wouters B; Lambin P; De Ruysscher D
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):649-55. PubMed ID: 15708242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiotherapy for early mediastinal Hodgkin lymphoma according to the German Hodgkin Study Group (GHSG): the roles of intensity-modulated radiotherapy and involved-node radiotherapy.
    Koeck J; Abo-Madyan Y; Lohr F; Stieler F; Kriz J; Mueller RP; Wenz F; Eich HT
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):268-76. PubMed ID: 22079733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical appraisal of Acuros XB and Anisotropic Analytic Algorithm dose calculation in advanced non-small-cell lung cancer treatments.
    Fogliata A; Nicolini G; Clivio A; Vanetti E; Cozzi L
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1587-95. PubMed ID: 22300575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential of adaptive radiotherapy to escalate the radiation dose in combined radiochemotherapy for locally advanced non-small cell lung cancer.
    Guckenberger M; Wilbert J; Richter A; Baier K; Flentje M
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):901-8. PubMed ID: 20708850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.